• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于砷的癌症药物。

Arsenical-based cancer drugs.

作者信息

Dilda Pierre J, Hogg Philip J

机构信息

UNSW Cancer Research Centre, University of New South Wales and Department of Haematology, Prince of Wales Hospital, Sydney 2052, Australia.

出版信息

Cancer Treat Rev. 2007 Oct;33(6):542-64. doi: 10.1016/j.ctrv.2007.05.001. Epub 2007 Jul 10.

DOI:10.1016/j.ctrv.2007.05.001
PMID:17624680
Abstract

Arsenic is a semi-metal or metalloid with two biologically important oxidation states, As(III) and As(V). As(III), in particular, reacts with closely spaced protein thiols, forming stable cyclic dithioarsinite complexes in which both sulfur atoms are bound to arsenic. It is this reaction that is mostly responsible for arsenics cytotoxicity. Arsenic compounds have been used as medicinal agents for many centuries for the treatment of diseases such as psoriasis, syphilis, and rheumatosis. From the 1700's until the introduction of and use of modern chemotherapy and radiation therapy in the mid 1900's, arsenic was a mainstay in the treatment of leukemia. Concerns about the toxicity of arsenical compounds led eventually to their abandonment for the treatment of cancer. The discovery in the 1980's that arsenic trioxide induces complete remission in a high percentage of patients with acute promyelocytic leukemia has awakened interest in this metalloid for the treatment of human disease. In particular, a new class or organoarsenicals are being trialed for the treatment of hematological malignancies and solid tumors. In this review, we discuss the arsenical-based compounds used in the past and present for the treatment of various forms of cancer. Mechanisms of action and selectivity and acute and chronic toxicities are discussed along with the prospects of this class of molecule.

摘要

砷是一种半金属或类金属,有两种对生物学重要的氧化态,即As(III)和As(V)。特别是As(III),它能与紧密相邻的蛋白质硫醇反应,形成稳定的环状二硫代亚砷酸盐配合物,其中两个硫原子都与砷结合。正是这个反应主要导致了砷的细胞毒性。几个世纪以来,砷化合物一直被用作药物来治疗诸如牛皮癣、梅毒和风湿病等疾病。从18世纪到20世纪中叶现代化疗和放射治疗被引入和使用之前,砷一直是治疗白血病的主要药物。对砷化合物毒性的担忧最终导致它们被弃用于癌症治疗。20世纪80年代发现三氧化二砷能使高比例的急性早幼粒细胞白血病患者完全缓解,这重新唤起了人们对这种类金属用于治疗人类疾病的兴趣。特别是,一类新型有机砷化合物正在试验用于治疗血液系统恶性肿瘤和实体瘤。在这篇综述中,我们讨论了过去和现在用于治疗各种癌症的含砷化合物。同时还讨论了其作用机制、选择性以及急性和慢性毒性,以及这类分子的前景。

相似文献

1
Arsenical-based cancer drugs.基于砷的癌症药物。
Cancer Treat Rev. 2007 Oct;33(6):542-64. doi: 10.1016/j.ctrv.2007.05.001. Epub 2007 Jul 10.
2
Introduction: the history of arsenic trioxide in cancer therapy.引言:三氧化二砷在癌症治疗中的历史。
Oncologist. 2001;6 Suppl 2:1-2. doi: 10.1634/theoncologist.6-suppl_2-1.
3
History of the development of arsenic derivatives in cancer therapy.癌症治疗中砷衍生物的发展历程。
Oncologist. 2001;6 Suppl 2:3-10. doi: 10.1634/theoncologist.6-suppl_2-3.
4
Darinaparsin: a novel organic arsenical with promising anticancer activity.达利那帕辛:一种具有良好抗癌活性的新型有机砷剂。
Expert Opin Investig Drugs. 2009 Nov;18(11):1727-34. doi: 10.1517/13543780903282759.
5
Arsenic trioxide in the management of acute promyelocytic leukaemia.三氧化二砷在急性早幼粒细胞白血病治疗中的应用
Natl Med J India. 2001 Jul-Aug;14(4):215-22.
6
Treatment of acute promyelocytic leukemia with arsenic trioxide without ATRA and/or chemotherapy.使用三氧化二砷而非全反式维甲酸和/或化疗治疗急性早幼粒细胞白血病。
Ann Oncol. 2006 Jan;17(1):131-4. doi: 10.1093/annonc/mdj019. Epub 2005 Oct 14.
7
Arsenic in medicine: past, present and future.医学中的砷:过去、现在和未来。
Biometals. 2023 Apr;36(2):283-301. doi: 10.1007/s10534-022-00371-y. Epub 2022 Feb 21.
8
Swallowing a bitter pill-oral arsenic trioxide for acute promyelocytic leukemia.咽下苦口良药——口服三氧化二砷治疗急性早幼粒细胞白血病
Blood Rev. 2016 May;30(3):201-11. doi: 10.1016/j.blre.2015.11.004. Epub 2015 Dec 3.
9
Arsenic trioxide as first-line treatment for acute promyelocytic leukemia.三氧化二砷作为急性早幼粒细胞白血病的一线治疗药物。
Am J Health Syst Pharm. 2009 Nov 1;66(21):1913-8. doi: 10.2146/ajhp080342.
10
Arsenic trioxide: new clinical experience with an old medication in hematologic malignancies.三氧化二砷:一种治疗血液系统恶性肿瘤的旧药的新临床经验。
J Clin Oncol. 2005 Apr 1;23(10):2396-410. doi: 10.1200/JCO.2005.10.217.

引用本文的文献

1
Unraveling the Puzzle: a Systematic Review of the Carcinogenic Role of Arsenic in Head and Neck Cancers.解开谜团:砷在头颈癌致癌作用中的系统评价
Biol Trace Elem Res. 2025 Jun 10. doi: 10.1007/s12011-025-04697-9.
2
Strain-Release Driven Arsenium Ion Bond Insertion.应变释放驱动的砷离子键插入
Angew Chem Int Ed Engl. 2025 Aug 25;64(35):e202510186. doi: 10.1002/anie.202510186. Epub 2025 Jul 24.
3
A Tunable Hydrogel Platform Based on Platinum-Containing Polymeric Arsenicals.基于含铂聚合砷化物的可调节水凝胶平台
Chem Mater. 2025 May 7;37(10):3733-3746. doi: 10.1021/acs.chemmater.5c00184. eCollection 2025 May 27.
4
Harnessing the Power of Traditional Chinese Medicine in Cancer Treatment: The Role of Nanocarriers.利用传统中药在癌症治疗中的力量:纳米载体的作用。
Int J Nanomedicine. 2025 Mar 13;20:3147-3174. doi: 10.2147/IJN.S502104. eCollection 2025.
5
Applications of liposomes and lipid nanoparticles in cancer therapy: current advances and prospects.脂质体和脂质纳米颗粒在癌症治疗中的应用:当前进展与展望
Exp Hematol Oncol. 2025 Jan 31;14(1):11. doi: 10.1186/s40164-025-00602-1.
6
Arsenic trioxide and p97 inhibitor synergize against acute myeloid leukemia by targeting nascent polypeptides and activating the ZAKα-JNK pathway.三氧化二砷和 p97 抑制剂通过靶向新生多肽和激活 ZAKα-JNK 通路协同作用于急性髓系白血病。
Cancer Gene Ther. 2024 Oct;31(10):1486-1497. doi: 10.1038/s41417-024-00818-z. Epub 2024 Aug 9.
7
Anticancer, anti-inflammatory and analgesic activities of aminoalcohol-based quinoxaline small molecules.基于氨基酸醇的喹喔啉小分子的抗癌、抗炎和镇痛活性。
Acta Cir Bras. 2024 Aug 5;39:e395124. doi: 10.1590/acb395124. eCollection 2024.
8
Design and Synthesis of Thiourea-Conjugating Organic Arsenic D-Glucose with Anticancer Activities.设计与合成具有抗癌活性的硫脲连接的有机砷-D-葡萄糖。
Molecules. 2024 Jun 14;29(12):2850. doi: 10.3390/molecules29122850.
9
As Nuclear Magnetic Resonance Spectroscopic Investigation of the Thioarsenate Speciation in Strongly Alkaline Sulfidic Leaching Solutions.强碱性硫化物浸出溶液中硫代砷酸盐形态的核磁共振光谱研究
Molecules. 2024 Jun 14;29(12):2848. doi: 10.3390/molecules29122848.
10
Pin1-catalyzed conformational regulation after phosphorylation: A distinct checkpoint in cell signaling and drug discovery.磷酸化后的 Pin1 催化构象调节:细胞信号转导和药物发现中的独特检查点。
Sci Signal. 2024 Jun 18;17(841):eadi8743. doi: 10.1126/scisignal.adi8743.